News

The patents cover the Momenta Pharma’s methods of producing Enoxaparin sodium, which assure that the commercial product meets standards for identity and quality. One patent, US Patent no.

The double- blind, single ascending dose study was conducted in 16 young healthy human volunteers, with 12 receiving ascending doses of GLPG0492 (ranging 0.5 to 120mg) and four

Zogenix and Desitin said Sumavel DosePro offers fast acting, easy-to-use, needle-free subcutaneous administration of sumatriptan and is designed for the acute treatment of migraine attacks, with or without

Topotecan for Injection is indicated for small cell lung cancer sensitive disease after failure of first-line chemotherapy, and is also indicated for use in combination therapy with Cisplatin

Norton Healthcare said the tie up will allow the company to aggregate and mine data in an efficient manner and will assist the Louisville, Ky.-based healthcare system in

AT-101 and AT-406 are both oral small molecules that trigger apoptosis (programmed cell death) at different points in the apoptosis pathways. As per the terms of the agreements,

As per the agreement, Baxter will exclusively license to Takeda its proprietary Vero cell-based influenza vaccine technology for the Japanese market. The companies will jointly pursue development and

Hybrigenics said that the transaction follows the successful completion of Phase IIa clinical tolerance study of oral inecalcitol in hormone-refractory prostate cancer patients. The first payment of EUR600,000

The marketing of FatigFix is a collaboration between Chrysalis and the technology holder Phynova Group, a UK company developing prescription as well as OTC drugs for healthcare and